BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 12467703)

  • 21. Potent second generation vinyl sulfonamide inhibitors of the trypanosomal cysteine protease cruzain.
    Roush WR; Cheng J; Knapp-Reed B; Alvarez-Hernandez A; McKerrow JH; Hansell E; Engel JC
    Bioorg Med Chem Lett; 2001 Oct; 11(20):2759-62. PubMed ID: 11591518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dissecting a novel allosteric mechanism of cruzain: A computer-aided approach.
    Hernández Alvarez L; Barreto Gomes DE; Hernández González JE; Pascutti PG
    PLoS One; 2019; 14(1):e0211227. PubMed ID: 30682119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crystal structure of the parasite inhibitor chagasin in complex with papain allows identification of structural requirements for broad reactivity and specificity determinants for target proteases.
    Redzynia I; Ljunggren A; Bujacz A; Abrahamson M; Jaskolski M; Bujacz G
    FEBS J; 2009 Feb; 276(3):793-806. PubMed ID: 19143838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. General solid-phase method to prepare novel cyclic ketone inhibitors of the cysteine protease cruzain.
    Huang L; Ellman JA
    Bioorg Med Chem Lett; 2002 Oct; 12(20):2993-6. PubMed ID: 12270191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular modeling and structure-activity relationships for a series of benzimidazole derivatives as cruzain inhibitors.
    Pauli I; Ferreira LG; de Souza ML; Oliva G; Ferreira RS; Dessoy MA; Slafer BW; Dias LC; Andricopulo AD
    Future Med Chem; 2017 May; 9(7):641-657. PubMed ID: 28509592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and synthesis of dipeptidyl alpha',beta'-epoxy ketones, potent irreversible inhibitors of the cysteine protease cruzain.
    Roush WR; González FV; McKerrow JH; Hansell E
    Bioorg Med Chem Lett; 1998 Oct; 8(19):2809-12. PubMed ID: 9873627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Production of crystallizable cruzain, the major cysteine protease from Trypanosoma cruzi.
    Eakin AE; McGrath ME; McKerrow JH; Fletterick RJ; Craik CS
    J Biol Chem; 1993 Mar; 268(9):6115-8. PubMed ID: 8454586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CoMFA and HQSAR of acylhydrazide cruzain inhibitors.
    Rodrigues CR; Flaherty TM; Springer C; McKerrow JH; Cohen FE
    Bioorg Med Chem Lett; 2002 Jun; 12(11):1537-41. PubMed ID: 12031337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mapping inhibitor binding modes on an active cysteine protease via nuclear magnetic resonance spectroscopy.
    Lee GM; Balouch E; Goetz DH; Lazic A; McKerrow JH; Craik CS
    Biochemistry; 2012 Dec; 51(50):10087-98. PubMed ID: 23181936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Computer-aided design of 1,4-naphthoquinone-based inhibitors targeting cruzain and rhodesain cysteine proteases.
    Silva LR; Guimarães AS; do Nascimento J; do Santos Nascimento IJ; da Silva EB; McKerrow JH; Cardoso SH; da Silva-Júnior EF
    Bioorg Med Chem; 2021 Jul; 41():116213. PubMed ID: 33992862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tetrafluorophenoxymethyl ketone cruzain inhibitors with improved pharmacokinetic properties as therapeutic leads for Chagas' disease.
    Neitz RJ; Bryant C; Chen S; Gut J; Hugo Caselli E; Ponce S; Chowdhury S; Xu H; Arkin MR; Ellman JA; Renslo AR
    Bioorg Med Chem Lett; 2015 Nov; 25(21):4834-4837. PubMed ID: 26144347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cysteine protease isoforms from Trypanosoma cruzi, cruzipain 2 and cruzain, present different substrate preference and susceptibility to inhibitors.
    Lima AP; dos Reis FC; Serveau C; Lalmanach G; Juliano L; Ménard R; Vernet T; Thomas DY; Storer AC; Scharfstein J
    Mol Biochem Parasitol; 2001 Apr; 114(1):41-52. PubMed ID: 11356512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peptidomimetic Vinyl Heterocyclic Inhibitors of Cruzain Effect Antitrypanosomal Activity.
    Chenna BC; Li L; Mellott DM; Zhai X; Siqueira-Neto JL; Calvet Alvarez C; Bernatchez JA; Desormeaux E; Alvarez Hernandez E; Gomez J; McKerrow JH; Cruz-Reyes J; Meek TD
    J Med Chem; 2020 Mar; 63(6):3298-3316. PubMed ID: 32125159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cruzain inhibition by hydroxymethylnitrofurazone and nitrofurazone: investigation of a new target in Trypanosoma cruzi.
    Trossini GH; Malvezzi A; T-do Amaral A; Rangel-Yagui CO; Izidoro MA; Cezari MH; Juliano L; Chin CM; Menezes CM; Ferreira EI
    J Enzyme Inhib Med Chem; 2010 Feb; 25(1):62-7. PubMed ID: 20030510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crystal structure of Leishmania mexicana cysteine protease B in complex with a high-affinity azadipeptide nitrile inhibitor.
    Ribeiro JFR; Cianni L; Li C; Warwick TG; de Vita D; Rosini F; Dos Reis Rocho F; Martins FCP; Kenny PW; Lameira J; Leitão A; Emsley J; Montanari CA
    Bioorg Med Chem; 2020 Nov; 28(22):115743. PubMed ID: 33038787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative structure-activity relationships for a series of inhibitors of cruzain from Trypanosoma cruzi: molecular modeling, CoMFA and CoMSIA studies.
    Trossini GH; Guido RV; Oliva G; Ferreira EI; Andricopulo AD
    J Mol Graph Model; 2009 Aug; 28(1):3-11. PubMed ID: 19376735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ligand-induced conformational selection predicts the selectivity of cysteine protease inhibitors.
    Sartori GR; Leitão A; Montanari CA; Laughton CA
    PLoS One; 2019; 14(12):e0222055. PubMed ID: 31856175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular Design, Synthesis and Trypanocidal Activity of Dipeptidyl Nitriles as Cruzain Inhibitors.
    Avelar LA; Camilo CD; de Albuquerque S; Fernandes WB; Gonçalez C; Kenny PW; Leitão A; McKerrow JH; Montanari CA; Orozco EV; Ribeiro JF; Rocha JR; Rosini F; Saidel ME
    PLoS Negl Trop Dis; 2015; 9(7):e0003916. PubMed ID: 26173110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design of Gallinamide A Analogs as Potent Inhibitors of the Cysteine Proteases Human Cathepsin L and
    Boudreau PD; Miller BW; McCall LI; Almaliti J; Reher R; Hirata K; Le T; Siqueira-Neto JL; Hook V; Gerwick WH
    J Med Chem; 2019 Oct; 62(20):9026-9044. PubMed ID: 31539239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel cruzain inhibitors for the treatment of Chagas' disease.
    Rogers KE; Keränen H; Durrant JD; Ratnam J; Doak A; Arkin MR; McCammon JA
    Chem Biol Drug Des; 2012 Sep; 80(3):398-405. PubMed ID: 22613098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.